What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond.
anticancer strategies
early detection
health care
multidisciplinary treatment
personalized oncology
radiation oncology
Journal
Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
11
05
2020
accepted:
25
05
2020
pubmed:
29
5
2020
medline:
2
7
2021
entrez:
29
5
2020
Statut:
ppublish
Résumé
The number of newly diagnosed cancers per year is predicted to almost double in the next two decades worldwide, and it remains unclear if and when this alarming trend will level off or even reverse. As such, cancer is very likely to continue to pose a major threat to human health. Radiation oncology is an indispensable pillar of cancer treatment and a well-developed discipline. Nevertheless, key trends in cancer research and care, including improved primary prevention, early detection, integrated multidisciplinary approaches, personalized strategies at all levels of care, value-based assessments of healthcare systems, and global health perspectives, will all shape the future of radiation oncology. Broader scientific advances, such as rapid progress in digitization, automation, and in our biological understanding of cancer, as well as the wider societal view of healthcare systems will also influence radiation oncology and how it is practiced. To stimulate a proactive discussion on how to adapt and reshape our discipline, this review provides some predictions on what the role and practice of radiation oncology might look like in 30 years' time.
Identifiants
pubmed: 32463984
doi: 10.1002/1878-0261.12731
pmc: PMC7332208
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1577-1585Informations de copyright
© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
Références
Dtsch Arztebl Int. 2018 Sep 3;115(35-36):578-585
pubmed: 30236216
Nat Rev Cancer. 2016 Apr;16(4):234-49
pubmed: 27009394
Nat Genet. 2020 Mar;52(3):306-319
pubmed: 32024998
Mol Oncol. 2019 Mar;13(3):521-527
pubmed: 30657633
Mol Oncol. 2020 Jul;14(7):1492-1499
pubmed: 32223048
Clin Cancer Res. 2016 Jun 1;22(11):2639-49
pubmed: 26755529
Dtsch Arztebl Int. 2018 Sep 3;115(35-36):571-577
pubmed: 30236215
Science. 2017 Mar 24;355(6331):1330-1334
pubmed: 28336671
Lancet Oncol. 2015 Sep;16(10):1144-6
pubmed: 26419349
Cell. 2020 Jun 11;181(6):1189-1193
pubmed: 32442404
Radiother Oncol. 2019 Jan;130:164-171
pubmed: 30033385
Dtsch Arztebl Int. 2018 Sep 3;115(35-36):586-593
pubmed: 30236218
Lancet Oncol. 2019 May;20(5):e262-e273
pubmed: 31044724
Nat Rev Clin Oncol. 2011 Mar;8(3):142-50
pubmed: 21364687
Radiother Oncol. 2018 Jul;128(1):26-36
pubmed: 29779919
Ann Oncol. 2019 May 1;30(5):781-787
pubmed: 30887043
Radiother Oncol. 2019 Oct;139:11-17
pubmed: 31253466
Radiother Oncol. 2014 Dec;113(3):317-23
pubmed: 25480095
Lancet Oncol. 2019 May;20(5):e253-e261
pubmed: 31044723
Cancer Discov. 2016 May;6(5):479-91
pubmed: 26969689
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
Cancer. 2018 Sep 15;124(18):3656-3667
pubmed: 30216477
Lancet Oncol. 2015 Sep;16(10):1153-86
pubmed: 26419354
Am Soc Clin Oncol Educ Book. 2019 Jan;39:332-340
pubmed: 31099640
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Radiother Oncol. 2019 Oct;139:1-3
pubmed: 31445836
CA Cancer J Clin. 2018 Jan;68(1):31-54
pubmed: 29160902
Radiother Oncol. 2016 Dec;121(3):364-373
pubmed: 27913065
Technol Cancer Res Treat. 2017 Dec;16(6):749-757
pubmed: 28592213
Nat Med. 2020 May;26(5):665-671
pubmed: 32405058
Mol Oncol. 2020 Jul;14(7):1529-1537
pubmed: 32112478
Lancet Oncol. 2019 Dec;20(12):1642-1644
pubmed: 32007189
Mol Oncol. 2019 Mar;13(3):624-635
pubmed: 30552794
Mol Oncol. 2019 Mar;13(3):567-578
pubmed: 30582778
Radiother Oncol. 2019 Apr;133:140-148
pubmed: 30935570
Radiother Oncol. 2018 Jul;128(1):56-67
pubmed: 29861141
Mol Oncol. 2012 Apr;6(2):111-27
pubmed: 22360993
Acta Oncol. 2019 Jun;58(6):916-925
pubmed: 30882264
Nat Rev Cancer. 2019 Mar;19(3):123-124
pubmed: 30683893
Nat Rev Clin Oncol. 2015 Jan;12(1):5-6
pubmed: 25421280
Radiother Oncol. 2018 Jul;128(1):1-3
pubmed: 30049367
Radiother Oncol. 2020 May;146:221-222
pubmed: 32389420
Nat Rev Cancer. 2006 Sep;6(9):702-13
pubmed: 16929324
J Clin Oncol. 2007 Sep 10;25(26):4066-74
pubmed: 17827455
Lancet Oncol. 2020 Jan;21(1):e18-e28
pubmed: 31908301